Table S2 from Novel BCL-2 Inhibitor Lisaftoclax in Relapsed or Refractory Chronic Lymphocytic Leukemia and Other Hematologic Malignancies: First-in-Human Open-Label Trial
openalex（2023）
摘要
Summary of BH3 profiling for PBMC samples collected at baseline.
更多查看译文
关键词
Treatment Discontinuation
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要